Abstract
Spontaneous intracerebral hemorrhage (ICH) is a dreaded complication of both cancer and its treatment. In the general population, ICH has a reported case fatality ratio of 36.6% at 7 days and 59% at 30 days. There is limited information on how the increased risks of bleeding in the oncologic population effects their survival. For example, while radiotherapy (RT) is an established treatment for primary and secondary brain tumors, it is also considered a risk factor for intracranial hemorrhage. This study aims to quantify the incidence of ICH and how prior cranial irradiation affects their short term survival.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
